One of the most potentially
troublesome portions of S. 3187 (FDA Safety and Innovation Act) is Section 708 regarding the handling and
disposition of imported prescription medicines which, under the authorization of the Secretary of
Health and Human Services (HHS), seized
medicines determined to be counterfeit, bogus, misbranded or of potential harm
to the health of American citizens, and determined to have a value of $2500 or
less, may be destroyed by the agency making the seizure.
The rules promulgation process is
nearing completion. After the rules are
presented for review and comment, there will be a 60-day period for
stakeholders, including TodaysSeniorsNetwork and
RxforAmericanHealth.blogspot.com, acting with other advocates of personal
importation on behalf of the more than
one million Americans for whom personal importation provides a lifeline to
vital drugs, to comment to urge rules that protect their continued access to these safe,
affordable medicines.
We anticipate that we will be a part
of a broad community of support, an
indication of which is a petition that was recently launched by Dr. Stephen
Barrett, a North Carolina physician who purchases his personal medications from
an Internet Pharmacy.
Dr. Barrett’s Petition urges HHS
Secretary Kathleen Sebelius to fully consider the potential harmful impact to
the health of Americans by the unwarranted seizure and destruction of medicines
that are safe and present no threat to Americans’ health.
We are heartened by Dr. Barrett’s concern
about the potentially harmful outcome of the misapplication of any rules that
might eventually emerge after stakeholders have the opportunity to be included
In the development of the final rules and their implementation, and are pleased
to preset the following information for your consideration and support.
The petition is located on http://www.change.org/petitions/kathleen-sebelius-please-don-t-stop-americans-from-getting-medicine-at-lower-cost-outside-the-u-s?utm_source=guides&utm_medium=email&utm_campaign=petition_created
.
No comments:
Post a Comment